| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2002;73:1732-1735
© 2002 The Society of Thoracic Surgeons
a Department of Basic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan
b Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
Accepted for publication February 6, 2002.
* Address reprint requests to Dr Hiroshima, Department of Basic Pathology, Graduate School of Medicine, Chiba University, 1-8-1 Inohona, Chuo-ku, Chiba 260-8670, Japan
e-mail: kenzo{at}med.m.chiba-u.ac.jp
Background. The relative incidence of adenocarcinoma of the lung is increasing and some patients with lung carcinoma, detected at an early stage, still develop recurrent disease despite complete resection of the tumor. Recently, neuroendocrine differentiation in large cell carcinoma of the lung has been reported to be of prognostic significance. Therefore, we have evaluated the prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung.
Methods. A total of 90 resected specimens of adenocarcinoma of the lung measuring 3 cm or less (T1 N0 M0 or T2 N0 M0) were reviewed histologically and immunohistochemical staining was performed to determine the degree of neuroendocrine differentiation.
Results. Seven adenocarcinomas exhibited neuroendocrine differentiation in 10% or more of tumor cells. The disease-free survival rate for these patients was significantly lower than that of patients with tumors exhibiting neuroendocrine differentiation in less than 10% of tumor cells or with absent neuroendocrine differentiation (p < 0.0005). Other conventional pathologic factors such as vascular invasion (p < 0.0005), lymphatic invasion (p < 0.05), and pleural involvement (p < 0.05) were also of prognostic significance. In multivariate analysis, the presence of 10% or more neuroendocrine marker-positive tumor cells, vascular invasion, and lymphatic invasion were found to be significantly adverse prognostic factors (p = 0.0162, p = 0.0111, and p = 0.0173, respectively).
Conclusions. Neuroendocrine differentiation of tumor cells is a prognostic factor in lung adenocarcinoma. It is suggested that the identification of neuroendocrine differentiation as well as vascular invasion by tumor in small peripheral adenocarcinoma of the lung may predict the prognosis of these patients.
This article has been cited by other articles:
|
|
 |
|
  C. A. Moran, S. Suster, D. Coppola, and M. R. Wick Neuroendocrine Carcinomas of the Lung: A Critical Analysis Am J Clin Pathol, February 1, 2009; 131(2): 206 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Iyoda, K. Hiroshima, Y. Nakatani, and T. Fujisawa Pulmonary Large Cell Neuroendocrine Carcinoma: Its Place in the Spectrum of Pulmonary Carcinoma Ann. Thorac. Surg., August 1, 2007; 84(2): 702 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Carolan, A. Heguy, B.-G. Harvey, P. L. Leopold, B. Ferris, and R. G. Crystal Up-regulation of Expression of the Ubiquitin Carboxyl-Terminal Hydrolase L1 Gene in Human Airway Epithelium of Cigarette Smokers. Cancer Res., November 15, 2006; 66(22): 10729 - 10740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Iyoda, K. Hiroshima, Y. Moriya, Y. Takiguchi, Y. Sekine, K. Shibuya, T. Iizasa, H. Kimura, Y. Nakatani, and T. Fujisawa Prospective Study of Adjuvant Chemotherapy for Pulmonary Large Cell Neuroendocrine Carcinoma Ann. Thorac. Surg., November 1, 2006; 82(5): 1802 - 1807. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
